These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16632485)

  • 1. The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1.
    Antonicka H; Sasarman F; Kennaway NG; Shoubridge EA
    Hum Mol Genet; 2006 Jun; 15(11):1835-46. PubMed ID: 16632485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The A3243G tRNALeu(UUR) MELAS mutation causes amino acid misincorporation and a combined respiratory chain assembly defect partially suppressed by overexpression of EFTu and EFG2.
    Sasarman F; Antonicka H; Shoubridge EA
    Hum Mol Genet; 2008 Dec; 17(23):3697-707. PubMed ID: 18753147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency.
    Coenen MJ; Antonicka H; Ugalde C; Sasarman F; Rossi R; Heister JG; Newbold RF; Trijbels FJ; van den Heuvel LP; Shoubridge EA; Smeitink JA
    N Engl J Med; 2004 Nov; 351(20):2080-6. PubMed ID: 15537906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in assembly or stability of complex I and other mitochondrial OXPHOS complexes in inherited complex I deficiency.
    Ugalde C; Janssen RJ; van den Heuvel LP; Smeitink JA; Nijtmans LG
    Hum Mol Genet; 2004 Mar; 13(6):659-67. PubMed ID: 14749350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The A3243G tRNALeu(UUR) mutation induces mitochondrial dysfunction and variable disease expression without dominant negative acting translational defects in complex IV subunits at UUR codons.
    Janssen GM; Hensbergen PJ; van Bussel FJ; Balog CI; Maassen JA; Deelder AM; Raap AK
    Hum Mol Genet; 2007 Oct; 16(20):2472-81. PubMed ID: 17656376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of small molecules on nuclear-encoded translation diseases.
    Soiferman D; Ayalon O; Weissman S; Saada A
    Biochimie; 2014 May; 100():184-91. PubMed ID: 24012549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu.
    Valente L; Tiranti V; Marsano RM; Malfatti E; Fernandez-Vizarra E; Donnini C; Mereghetti P; De Gioia L; Burlina A; Castellan C; Comi GP; Savasta S; Ferrero I; Zeviani M
    Am J Hum Genet; 2007 Jan; 80(1):44-58. PubMed ID: 17160893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct clinical phenotypes associated with a mutation in the mitochondrial translation elongation factor EFTs.
    Smeitink JA; Elpeleg O; Antonicka H; Diepstra H; Saada A; Smits P; Sasarman F; Vriend G; Jacob-Hirsch J; Shaag A; Rechavi G; Welling B; Horst J; Rodenburg RJ; van den Heuvel B; Shoubridge EA
    Am J Hum Genet; 2006 Nov; 79(5):869-77. PubMed ID: 17033963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-exome sequencing identifies a mutation in the mitochondrial ribosome protein MRPL44 to underlie mitochondrial infantile cardiomyopathy.
    Carroll CJ; Isohanni P; Pöyhönen R; Euro L; Richter U; Brilhante V; Götz A; Lahtinen T; Paetau A; Pihko H; Battersby BJ; Tyynismaa H; Suomalainen A
    J Med Genet; 2013 Mar; 50(3):151-9. PubMed ID: 23315540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation in subdomain G' of mitochondrial elongation factor G1 is associated with combined OXPHOS deficiency in fibroblasts but not in muscle.
    Smits P; Antonicka H; van Hasselt PM; Weraarpachai W; Haller W; Schreurs M; Venselaar H; Rodenburg RJ; Smeitink JA; van den Heuvel LP
    Eur J Hum Genet; 2011 Mar; 19(3):275-9. PubMed ID: 21119709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toward genotype phenotype correlations in GFM1 mutations.
    Galmiche L; Serre V; Beinat M; Zossou R; Assouline Z; Lebre AS; Chretien F; Shenhav R; Zeharia A; Saada A; Vedrenne V; Boddaert N; de Lonlay P; Rio M; Munnich A; Rötig A
    Mitochondrion; 2012 Mar; 12(2):242-7. PubMed ID: 21986555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis of the oxidative phosphorylation complexes in skeletal muscle from patients with mitochondrial DNA encoded tRNA gene defects.
    De Paepe B; Smet J; Lammens M; Seneca S; Martin JJ; De Bleecker J; De Meirleir L; Lissens W; Van Coster R
    J Clin Pathol; 2009 Feb; 62(2):172-6. PubMed ID: 19181635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial hepatopathies in the newborn period.
    Fellman V; Kotarsky H
    Semin Fetal Neonatal Med; 2011 Aug; 16(4):222-8. PubMed ID: 21680270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exome sequencing identifies MRPL3 mutation in mitochondrial cardiomyopathy.
    Galmiche L; Serre V; Beinat M; Assouline Z; Lebre AS; Chretien D; Nietschke P; Benes V; Boddaert N; Sidi D; Brunelle F; Rio M; Munnich A; Rötig A
    Hum Mutat; 2011 Nov; 32(11):1225-31. PubMed ID: 21786366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysfunctional mitochondrial translation and combined oxidative phosphorylation deficiency in a mouse model of hepatoencephalopathy due to Gfm1 mutations.
    Molina-Berenguer M; Vila-Julià F; Pérez-Ramos S; Salcedo-Allende MT; Cámara Y; Torres-Torronteras J; Martí R
    FASEB J; 2022 Jan; 36(1):e22091. PubMed ID: 34919756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of new techniques for locating the underlying molecular defects in patients with disorders of oxidative phosphorylation].
    Van Coster R; Smet J
    Verh K Acad Geneeskd Belg; 2007; 69(4):197-211. PubMed ID: 17821958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation in the mitochondrial translation elongation factor EFTs results in severe infantile liver failure.
    Vedrenne V; Galmiche L; Chretien D; de Lonlay P; Munnich A; Rötig A
    J Hepatol; 2012 Jan; 56(1):294-7. PubMed ID: 21741925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses.
    Gibson K; Halliday JL; Kirby DM; Yaplito-Lee J; Thorburn DR; Boneh A
    Pediatrics; 2008 Nov; 122(5):1003-8. PubMed ID: 18977979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contiguous gene deletion of ELOVL7, ERCC8 and NDUFAF2 in a patient with a fatal multisystem disorder.
    Janssen RJ; Distelmaier F; Smeets R; Wijnhoven T; Østergaard E; Jaspers NG; Raams A; Kemp S; Rodenburg RJ; Willems PH; van den Heuvel LP; Smeitink JA; Nijtmans LG
    Hum Mol Genet; 2009 Sep; 18(18):3365-74. PubMed ID: 19525295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective mitochondrial translation caused by a ribosomal protein (MRPS16) mutation.
    Miller C; Saada A; Shaul N; Shabtai N; Ben-Shalom E; Shaag A; Hershkovitz E; Elpeleg O
    Ann Neurol; 2004 Nov; 56(5):734-8. PubMed ID: 15505824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.